Clinical Protocol & Data Management (CPDM) is the centralized clinical component of the UNM Cancer Center Clinical Research Office that manages the initiation, ongoing maintenance and reporting of all clinical research, including population science studies. It works closely with the New Mexico Cancer Care Alliance to provide a fully integrated clinical research management system for cancer clinical trials and community based studies throughout New Mexico.
Melanie Royce, MD, PhD, continues to lead the CPDM. Dr. Royce is an expert in breast cancer. She is a Professor of Medicine at the UNM School of Medicine, Director of the UNM Cancer Center Multidisciplinary Breast Cancer Program, and Co-Principal Investigator of the New Mexico Minority NCORP grant.
The CPDM administers 345 clinical research studies annually (on average) across the UNM Cancer Center and NMCCA. The amount of time needed to open a clinical research study has dropped dramatically over the past five years. The CPDM tracked 1226 people on therapeutic intervention trials between January 2010 and June 30, 2014. A significant number of these people represented groups that are not well represented in clinical trials, such as women, Hispanics/Latinos and Native Americans.